283 related articles for article (PubMed ID: 36031013)
1. Loss of BTK ameliorates the pathological cardiac fibrosis and dysfunction.
Wang B; Tan Y; Zhou W; Yang J; Jiang Y; Liu X; Zhan Z
Matrix Biol; 2022 Sep; 112():171-189. PubMed ID: 36031013
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis.
Khalil H; Kanisicak O; Prasad V; Correll RN; Fu X; Schips T; Vagnozzi RJ; Liu R; Huynh T; Lee SJ; Karch J; Molkentin JD
J Clin Invest; 2017 Oct; 127(10):3770-3783. PubMed ID: 28891814
[TBL] [Abstract][Full Text] [Related]
3. Loss of KDM5B ameliorates pathological cardiac fibrosis and dysfunction by epigenetically enhancing ATF3 expression.
Wang B; Tan Y; Zhang Y; Zhang S; Duan X; Jiang Y; Li T; Zhou Q; Liu X; Zhan Z
Exp Mol Med; 2022 Dec; 54(12):2175-2187. PubMed ID: 36481938
[TBL] [Abstract][Full Text] [Related]
4. TNAP is a novel regulator of cardiac fibrosis after myocardial infarction by mediating TGF-β/Smads and ERK1/2 signaling pathways.
Cheng X; Wang L; Wen X; Gao L; Li G; Chang G; Qin S; Zhang D
EBioMedicine; 2021 May; 67():103370. PubMed ID: 33971401
[TBL] [Abstract][Full Text] [Related]
5. Smad7 effects on TGF-β and ErbB2 restrain myofibroblast activation and protect from postinfarction heart failure.
Humeres C; Shinde AV; Hanna A; Alex L; Hernández SC; Li R; Chen B; Conway SJ; Frangogiannis NG
J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 34905511
[TBL] [Abstract][Full Text] [Related]
6. Protective Effects of Activated Myofibroblasts in the Pressure-Overloaded Myocardium Are Mediated Through Smad-Dependent Activation of a Matrix-Preserving Program.
Russo I; Cavalera M; Huang S; Su Y; Hanna A; Chen B; Shinde AV; Conway SJ; Graff J; Frangogiannis NG
Circ Res; 2019 Apr; 124(8):1214-1227. PubMed ID: 30686120
[TBL] [Abstract][Full Text] [Related]
7. Mitoquinone ameliorates pressure overload-induced cardiac fibrosis and left ventricular dysfunction in mice.
Goh KY; He L; Song J; Jinno M; Rogers AJ; Sethu P; Halade GV; Rajasekaran NS; Liu X; Prabhu SD; Darley-Usmar V; Wende AR; Zhou L
Redox Biol; 2019 Feb; 21():101100. PubMed ID: 30641298
[TBL] [Abstract][Full Text] [Related]
8. Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation.
Stratton MS; Bagchi RA; Felisbino MB; Hirsch RA; Smith HE; Riching AS; Enyart BY; Koch KA; Cavasin MA; Alexanian M; Song K; Qi J; Lemieux ME; Srivastava D; Lam MPY; Haldar SM; Lin CY; McKinsey TA
Circ Res; 2019 Sep; 125(7):662-677. PubMed ID: 31409188
[TBL] [Abstract][Full Text] [Related]
9. SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation.
Landry NM; Rattan SG; Filomeno KL; Meier TW; Meier SC; Foran SJ; Meier CF; Koleini N; Fandrich RR; Kardami E; Duhamel TA; Dixon IMC
Basic Res Cardiol; 2021 Apr; 116(1):25. PubMed ID: 33847835
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure.
Verjans R; Peters T; Beaumont FJ; van Leeuwen R; van Herwaarden T; Verhesen W; Munts C; Bijnen M; Henkens M; Diez J; de Windt LJ; van Nieuwenhoven FA; van Bilsen M; Goumans MJ; Heymans S; González A; Schroen B
Hypertension; 2018 Feb; 71(2):280-288. PubMed ID: 29255073
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of myoblast sheets that secrete the novel peptide SVVYGLR improves cardiac function in failing hearts.
Uchinaka A; Kawaguchi N; Hamada Y; Mori S; Miyagawa S; Saito A; Sawa Y; Matsuura N
Cardiovasc Res; 2013 Jul; 99(1):102-10. PubMed ID: 23615564
[TBL] [Abstract][Full Text] [Related]
12. Regulation of cardiac fibroblast-mediated maladaptive ventricular remodeling by β-arrestins.
Philip JL; Xu X; Han M; Akhter SA; Razzaque MA
PLoS One; 2019; 14(7):e0219011. PubMed ID: 31269046
[TBL] [Abstract][Full Text] [Related]
13. Bruton's Tyrosine Kinase Inhibition Attenuates the Cardiac Dysfunction Caused by Cecal Ligation and Puncture in Mice.
O'Riordan CE; Purvis GSD; Collotta D; Chiazza F; Wissuwa B; Al Zoubi S; Stiehler L; Martin L; Coldewey SM; Collino M; Thiemermann C
Front Immunol; 2019; 10():2129. PubMed ID: 31552054
[TBL] [Abstract][Full Text] [Related]
14. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
Lian R; Chen Y; Xu Z; Zhang X
Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
[TBL] [Abstract][Full Text] [Related]
15. Cytokine-Like 1 Regulates Cardiac Fibrosis via Modulation of TGF-β Signaling.
Kim J; Kim J; Lee SH; Kepreotis SV; Yoo J; Chun JS; Hajjar RJ; Jeong D; Park WJ
PLoS One; 2016; 11(11):e0166480. PubMed ID: 27835665
[TBL] [Abstract][Full Text] [Related]
16. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
[TBL] [Abstract][Full Text] [Related]
17. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Cho N; Razipour SE; McCain ML
Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
[TBL] [Abstract][Full Text] [Related]
18. Haplodeficiency of activin receptor-like kinase 4 alleviates myocardial infarction-induced cardiac fibrosis and preserves cardiac function.
Chen YH; Wang Q; Li CY; Hou JW; Chen XM; Zhou Q; Chen J; Wang YP; Li YG
J Mol Cell Cardiol; 2017 Apr; 105():1-11. PubMed ID: 28214509
[TBL] [Abstract][Full Text] [Related]
19. Nuclear Receptor Nur77 Controls Cardiac Fibrosis through Distinct Actions on Fibroblasts and Cardiomyocytes.
Medzikovic L; Heese H; van Loenen PB; van Roomen CPAA; Hooijkaas IB; Christoffels VM; Creemers EE; de Vries CJM; de Waard V
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562500
[TBL] [Abstract][Full Text] [Related]
20. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
